Oragenics, Inc. OGEN 深 滬
交易中 07-18 11:47:01 美东时间
1.3999
-0.030
-2.10%
華盛通- 最 高1.4399
- 今 開1.43
- 成交量 5.95万股
- 最 低 1.37
- 昨 收 1.43
- 總市值 100.20万
- 52周最高 75.60
- 市盈率 靜 --
- 換手率 8.32%
- 52周最低 1.30
- 委 比 -20.52%
- 總股本 71.58万
- 歷史最高 83700.00
- 量 比 0.45
- 振 幅 4.89%
- 歷史最低 1.37
- 每 手 1
- 風險率 1.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oragenics Enters Manufacturing Agreement With Sterling Pharma For GMP Production Of Concussion Drug, ONP-002
Oragenics, Inc. (NYSE:OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufacturing agreement with Sterling Pharma Solutions, an
07-16 20:41
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
Oragenics, a biotech company developing intranasal therapeutics for brain-related conditions, has partnered with Sterling Pharma Solutions for GMP production of its lead drug candidate, ONP-002, to treat concussions. This collaboration aims to support planned Phase IIb clinical trials starting next year. The partnership underscores Oragenics' commitment to quality, efficiency, and U.S.-based innovation, while Sterling's expertise in CNS therapies...
07-16 12:39
“痛风”鏖战：西方不亮东方亮？
（转自：氨基观察） 当高尿酸血症以1.77亿患病人数成为我国“第四高”，现有治疗药物却仍深陷局限困局。 非布司他心血管风险争议如影随形，苯溴马隆肝毒性隐患挥之...
07-14 11:11
Oragenics Raises $16.5M Through Public Offering
Oragenics ( ($OGEN) ) has issued an announcement. On July 1, 2025, Oragenics, I...
07-03 04:45
Oragenics Completes Approximately $16.5 Million Offering
Oragenics, Inc. has successfully completed a public offering of Series H Convertible Preferred Stock and Warrants, raising approximately $16.5 million. The company plans to use the proceeds to advance the clinical development of ONP-002, its intranasal drug candidate for mild traumatic brain injury, as well as for other R&D activities, debt repayment, and general corporate purposes. The offering also includes potential additional proceeds of $16....
07-02 20:15
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neurogene (NASDAQ:NGNE) shares increased by 32.3% to $19.77 during Tue...
07-02 01:05
Oragenics Prices Public Offering Of Up To $20M Of Preferred Stock And Warrants
Oragenics, Inc. (NYSE:OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for
07-01 20:35
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Thumzup Media Corporation (NASDAQ:TZUP) rose sharply in today's pre-m...
07-01 17:23
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants
Oragenics, Inc. has entered into a placement agency agreement to sell up to 800,000 shares of Series H Convertible Preferred Stock and Warrants, with a combined offering price of $25.00 per unit. The offering is expected to raise up to $20 million, net proceeds of which will fund concussion clinical trials, repay a $3 million bridge note, and support general corporate purposes. Dawson James Securities, Inc. is acting as the sole placement agent. ...
07-01 12:31
Neogen Chemicals Confirms Stable Shareholding Structure for FY 2025
Neogen Chemicals Ltd. ( ($IN:NEOGEN) ) just unveiled an announcement. Neogen Ch...
06-30 00:12
